4LB9
EVP: (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
EVP is a Ligand Of Interest in 4LB9 designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4LB9_EVP_A_605 | 46% | 2% | 0.108 | 0.84 | 3.83 | 2.93 | 18 | 33 | 1 | 0 | 100% | 1 |
| 3QX3_EVP_D_1 | 91% | 2% | 0.09 | 0.975 | 4.22 | 2.32 | 23 | 25 | 1 | 0 | 100% | 1 |
| 5ZRF_EVP_D_101 | 81% | 1% | 0.118 | 0.972 | 5.6 | 1.78 | 26 | 14 | 0 | 0 | 100% | 1 |
| 5CDP_EVP_H_2101 | 58% | 37% | 0.139 | 0.917 | 0.78 | 1.68 | 1 | 12 | 1 | 0 | 100% | 1 |
| 5CDN_EVP_N_2101 | 58% | 32% | 0.171 | 0.949 | 0.77 | 1.91 | 1 | 12 | 0 | 0 | 100% | 1 |
| 5GWK_EVP_D_102 | 20% | 1% | 0.294 | 0.901 | 4.58 | 2.68 | 25 | 28 | 2 | 0 | 100% | 1 |
